DRUG COMBINATION HAVING ANTI-TUMOR EFFICACY
The present invention provides a drug combination having anti-tumor efficacy, comprising a cinnamic acid derivative and an anti-tumor drug that have unit formulations of the same or different specifications and are used for simultaneous or separate administration, and a pharmaceutically acceptable c...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | Chinese English French |
Published |
01.03.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a drug combination having anti-tumor efficacy, comprising a cinnamic acid derivative and an anti-tumor drug that have unit formulations of the same or different specifications and are used for simultaneous or separate administration, and a pharmaceutically acceptable carrier. By means of the combination of a trans-cinnamic acid derivative and an anti-tumor drug, the present invention can produce a synergistic effect, and can also achieve a toxicity reduction effect in combination with some anti-tumor drugs. The present invention has a broad prospect in clinical application.
La présente invention concerne une combinaison de médicaments présentant une efficacité antitumorale, comprenant un dérivé d'acide cinnamique et un médicament antitumoral qui présentent des formulations unitaires de spécifications identiques ou différentes et qui sont utilisés pour une administration simultanée ou séparée et un support pharmaceutiquement acceptable. Au moyen de la combinaison d'un dérivé d'ac |
---|---|
Bibliography: | Application Number: WO2016CN97789 |